Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6860198rdf:typepubmed:Citationlld:pubmed
pubmed-article:6860198lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6860198lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:6860198lifeskim:mentionsumls-concept:C0016353lld:lifeskim
pubmed-article:6860198pubmed:issue6lld:pubmed
pubmed-article:6860198pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:6860198pubmed:abstractTextVitreous fluorophotometry performed on 22 patients with moderate to severe hypertension showed that patients with active retinopathy, as manifested by retinal hemorrhages, cotton-wool spots, retinal exudates and edema, or disc edema, generally had elevated values (20/28 eyes). Control of the BP resulted in a decrease in the values toward the normal range. Patients with only arteriolar sclerosis, even some with particularly high BP, generally had normal fluorophotometric values (14/16 eyes). The two exceptions showed minimal elevations. Vitreous fluorophotometry is a useful tool to quantitate the blood-retinal barrier in patients with moderate to severe hypertension and may be a sensitive indicator of treatment efficacy.lld:pubmed
pubmed-article:6860198pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6860198pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6860198pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6860198pubmed:languageenglld:pubmed
pubmed-article:6860198pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6860198pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6860198pubmed:statusMEDLINElld:pubmed
pubmed-article:6860198pubmed:monthJunlld:pubmed
pubmed-article:6860198pubmed:issn0003-9950lld:pubmed
pubmed-article:6860198pubmed:authorpubmed-author:JampolL MLMlld:pubmed
pubmed-article:6860198pubmed:authorpubmed-author:WhiteSSlld:pubmed
pubmed-article:6860198pubmed:authorpubmed-author:Cunha-VazJJlld:pubmed
pubmed-article:6860198pubmed:issnTypePrintlld:pubmed
pubmed-article:6860198pubmed:volume101lld:pubmed
pubmed-article:6860198pubmed:ownerNLMlld:pubmed
pubmed-article:6860198pubmed:authorsCompleteYlld:pubmed
pubmed-article:6860198pubmed:pagination888-90lld:pubmed
pubmed-article:6860198pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6860198pubmed:meshHeadingpubmed-meshheading:6860198-...lld:pubmed
pubmed-article:6860198pubmed:meshHeadingpubmed-meshheading:6860198-...lld:pubmed
pubmed-article:6860198pubmed:meshHeadingpubmed-meshheading:6860198-...lld:pubmed
pubmed-article:6860198pubmed:meshHeadingpubmed-meshheading:6860198-...lld:pubmed
pubmed-article:6860198pubmed:meshHeadingpubmed-meshheading:6860198-...lld:pubmed
pubmed-article:6860198pubmed:meshHeadingpubmed-meshheading:6860198-...lld:pubmed
pubmed-article:6860198pubmed:year1983lld:pubmed
pubmed-article:6860198pubmed:articleTitleVitreous fluorophotometry in patients with hypertension.lld:pubmed
pubmed-article:6860198pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6860198pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6860198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6860198lld:pubmed